Literature DB >> 19415722

Nutritional deficiencies in iron overloaded patients with hemoglobinopathies.

Susan Claster1, John C Wood, Leila Noetzli, Susan M Carson, Thomas C Hofstra, Rachna Khanna, Thomas D Coates.   

Abstract

One of the hallmarks of both sickle cell disease (SCD) and thalassemia major (TM) is accelerated oxidative damage. Decreased antioxidant levels and increased oxidant stress biomarkers are found in both diseases. Although isolated vitamin deficiencies have been reported in TM and nontransfused SCD patients, a comprehensive evaluation of vitamin and trace mineral levels has never been performed in chronically transfused SCD or TM patients. As vitamins and trace minerals may be consumed as a result of chronic oxidative stress; we hypothesized that levels of these compounds would correlate with surrogates of iron overload, hemolysis, and inflammation in chronically transfused patients. Using a convenience sample of our group of chronically transfused patients we studied 43 patients with SCD (17 male, 26 female) and 24 patients with TM (13 male and 11 female). The age range for our patients varied from 1.5 to 31.4 years. Levels of vitamins A, thiamin, B6, B12, C, D, E as well as selenium, zinc, copper, and ceruloplasmin were measured. We found that 40-75% of the patients were deficient in A, C, D and selenium and 28-38% of the patients had low levels of B vitamins and folate. There was little association with iron overload, hemolysis, or inflammation. Although the precise mechanism of these deficiencies is unclear, they may contribute to the morbidity of chronically transfused hemoglobinopathy patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415722      PMCID: PMC2887656          DOI: 10.1002/ajh.21416

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  42 in total

1.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  Total and resting energy expenditure in children with sickle cell disease.

Authors:  E M Barden; B S Zemel; D A Kawchak; M I Goran; K Ohene-Frempong; V A Stallings
Journal:  J Pediatr       Date:  2000-01       Impact factor: 4.406

3.  Effect of zinc supplementation on growth and body composition in children with sickle cell disease.

Authors:  Babette S Zemel; Deborah A Kawchak; Ellen B Fung; Kwaku Ohene-Frempong; Virginia A Stallings
Journal:  Am J Clin Nutr       Date:  2002-02       Impact factor: 7.045

4.  Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency.

Authors:  C K Mukhopadhyay; B Mazumder; P L Fox
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

5.  Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor.

Authors:  Suresh K Selvaraj; Ranjit K Giri; Natalya Perelman; Cage Johnson; Punam Malik; Vijay K Kalra
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

6.  Red blood cell folate and serum vitamin B12 status in children with sickle cell disease.

Authors:  T S Kennedy; E B Fung; D A Kawchak; B S Zemel; K Ohene-Frempong; V A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2001 Mar-Apr       Impact factor: 1.289

Review 7.  Vitamin A supplementation: implications for morbidity and mortality in children.

Authors:  E Villamor; W W Fawzi
Journal:  J Infect Dis       Date:  2000-09       Impact factor: 5.226

8.  Placenta growth factor activates monocytes and correlates with sickle cell disease severity.

Authors:  Natalya Perelman; Suresh K Selvaraj; Sandeep Batra; Lori R Luck; Anat Erdreich-Epstein; Thomas D Coates; Vijay K Kalra; Punam Malik
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

9.  Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis.

Authors:  S S Marwah; A D Blann; C Rea; J D Phillips; J Wright; D Bareford
Journal:  Am J Hematol       Date:  2002-02       Impact factor: 10.047

10.  Vitamin B6 status of children with sickle cell disease.

Authors:  Melissa C Nelson; Babette S Zemel; Deborah A Kawchak; Elizabeth M Barden; Edward A Frongillo; Stephen P Coburn; Kwaku Ohene-Frempong; Virginia A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2002 Aug-Sep       Impact factor: 1.289

View more
  31 in total

1.  Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis.

Authors:  Sylvia T Singer; David Killilea; Jung H Suh; Zhiyue Jerry Wang; Qing Yuan; Kristen Ivani; Patricia Evans; Elliott Vichinsky; Roland Fischer; James F Smith
Journal:  Am J Hematol       Date:  2015-07-22       Impact factor: 10.047

2.  Different morphological and gene expression profile in placentas of the same sickle cell anemia patient in pregnancies of opposite outcomes.

Authors:  Letícia C Baptista; Camilla O Figueira; Bruno B Souza; Kleber Y Fertrin; Arthur Antolini; Fernando F Costa; Mônica B de Melo; Maria Laura Costa
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-28

3.  Electrocardiographic consequences of cardiac iron overload in thalassemia major.

Authors:  Jon Detterich; Leila Noetzli; Fred Dorey; Yaniv Bar-Cohen; Paul Harmatz; Thomas Coates; John Wood
Journal:  Am J Hematol       Date:  2011-11-04       Impact factor: 10.047

Review 4.  Evolving treatment paradigms in sickle cell disease.

Authors:  Ramasamy Jagadeeswaran; Angela Rivers
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 5.  Iron-chelating therapy for transfusional iron overload.

Authors:  Gary M Brittenham
Journal:  N Engl J Med       Date:  2011-01-13       Impact factor: 91.245

Review 6.  How we manage iron overload in sickle cell patients.

Authors:  Thomas D Coates; John C Wood
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

Review 7.  Association of chromosome damage detected as micronuclei with hematological diseases and micronutrient status.

Authors:  Ashutosh Lal; Bruce N Ames
Journal:  Mutagenesis       Date:  2011-01       Impact factor: 3.000

Review 8.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

Review 9.  Cardiac complications in thalassemia major.

Authors:  John C Wood
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

10.  Methemoglobinemia and ascorbate deficiency in hemoglobin E β thalassemia: metabolic and clinical implications.

Authors:  Angela Allen; Christopher Fisher; Anuja Premawardhena; Dayananda Bandara; Ashok Perera; Stephen Allen; Timothy St Pierre; Nancy Olivieri; David Weatherall
Journal:  Blood       Date:  2012-08-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.